When will the FDA reclassify BPC-157 to Category 1?
As of Sun, 22 Nov 2026 00:49:22 UTC, Kalshi traders price Yes (5.0%). The market has $149K in volume and closes on Fri, 01 Jan 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| Yes | 5.0% | 5.0¢ | 95.0¢ |
Market details
- Venue: Kalshi
- Volume: $149K
- Liquidity: $149K
- Closes:
Resolution rules
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes. The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.
Sources
Related markets
- Will the FDA approve retatrutide?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- Will the U.S. confirm that aliens exist?
- Best AI at the end of 2026?
- When will Anthropic release Mythos?
- Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
More markets like this
- Will the FDA approve a cure for Type 1 diabetes before 2033?
- Will the FDA approve CagriSema?
- Will the FDA approve VERVE-102?
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (this year)
- When will the first 2028 Republican primary debate be?
- When will the first listed Democrat announce a 2028 presidential run?
- When will the first listed Republican announce a 2028 presidential run?
- When will the first useful quantum computer be developed?
A price on DOXA is the market-implied probability of an outcome on the venue that lists it. It is what traders are paying, not a forecast made by DOXA, and it is not investment advice. How DOXA shows prices · Terms of Use
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.